Evolution of Glycan Diversity
An enzymatic process called as glycosylation facilitate glycans to attach a wide variety of biological molecules through to enhance their role. Glycans are found in archaea, bacteria and eukaryotes, and their varied roles contribute to maintain physical and structural integrity, formation of extracellular matrix, signal transduction, protein folding and information exchange between cells (and pathogens). Glycans are the major molecule on the cell surface and function as the primary point of interaction between a cell and other cells, the extracellular matrix and pathogens. The intensified evolutionary pressure of being at the front lines of cellular collaboration and conflict most likely led to the modification of glycans. Glyco-epitope diversity augments the function of glycans in the group of debilitating and life-shortening disorders known as congenital muscular dystrophy, or CMD. Both ECM and the membrane proteins are highly glycosylated, and O-glycans are vital for proper ECM function and communication between cells and the ECM. Numerous Glycoepitomics forms of CMD are known to result from dysfunctional O-glycosylation of membrane and ECM proteins; however, one-third of CMDs arise from an unknown genetic etiology.
- Biochemical analysis of lipids & proteins
- Glycan structural modelling
- Comparative Glycomics
- Synthesis systems of glycans
- Glyco-epitope Diversity
- Glycoepitomics
Related Conference of Evolution of Glycan Diversity
Evolution of Glycan Diversity Conference Speakers
Recommended Sessions
- Evolution of Glycan Diversity
- Glycan Catabolism and Systemic Physiology
- Glycans in Diseases and Therapeutics
- Glycans in Drug Design
- Glycans in Structural and Computational Systems Biology
- Glycans in Vaccine Development
- Glyco Immunology
- Glycobiology and Biotechnology
- Glycobiology and Glycochemistry
- Glycobiology in Lipid Science
- Glycobiology: It’s Role in Human Health
- Glycoconjugates, Glycomics and Transcriptomics
- Glycomics and Metabolomics
- Glyconeurobiology: Glycans in Neuroscience
- Glycopathology: Glycans in Cancer
- Glycosciences and Monosaccharides
- Mass Spectrometry Analysis
- Recent Advances in Glycobiology
- Structural Bioinformatics and Proteomics
- Synthesis and Biological Role of Glycans
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Drug Delivery Systems for Metabolic Therapy - DRUG CHEMISTRY CONF 2026 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomarker-Guided Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Chemical Biology Tools in Metabolic Research - DRUG CHEMISTRY CONF 2026 (France)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Drug Design and Molecular Modeling - DRUG CHEMISTRY CONF 2026 (France)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Drug Resistance and Therapeutic Durability - DRUG CHEMISTRY CONF 2026 (France)
- Enzyme Modulation Approaches in Antidiabetic Drug Design - DRUG CHEMISTRY CONF 2026 (France)
- Epigenetic Regulation and Small-Molecule Therapeutics - DRUG CHEMISTRY CONF 2026 (France)
- Future Directions in Drug Chemistry for Diabetes Management - DRUG CHEMISTRY CONF 2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Lipid Chemistry and Metabolic Regulation - DRUG CHEMISTRY CONF 2026 (France)
- Medicinal Chemistry Strategies for Metabolic Disorders - DRUG CHEMISTRY CONF 2026 (France)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Natural Product Chemistry in Diabetes Drug Discovery - DRUG CHEMISTRY CONF 2026 (France)
- Oxidative Stress Modulation through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Peptide and Protein-Based Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Pharmacokinetics and Drug Metabolism Studies - DRUG CHEMISTRY CONF 2026 (France)
- Prodrug Design and Chemical Activation Strategies - DRUG CHEMISTRY CONF 2026 (France)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Regulatory Chemistry and Drug Safety Assessment - DRUG CHEMISTRY CONF 2026 (France)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- Structure–Activity Relationship Studies in Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Synthetic Chemistry Innovations in Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Targeting Pancreatic Function through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Translational Drug Chemistry from Bench to Clinic - DRUG CHEMISTRY CONF 2026 (France)
